Emilia Vynnycky is an infectious disease modeller. She currently works on rubella and has previously worked for many years on tuberculoais as well as influenza. She is employed by UKHSA and has an honorary time position at LSHTM. She is also part of the Vaccine Impact Modelling Consortium
Affiliations
Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health
Centres
Centre for Mathematical Modelling of Infectious Diseases
TB Centre
Vaccine Centre
Teaching
Emilia co-organises the MSc module on Modelling and the Dynamics of Infectious Diseases (with Richard White and Lara Gosce) as well as the LSHTM-UKHSA shortcourse "An introduction to infectious disease modelling and its applications" (with Richard White and Nicky McCreesh). She is also co-author of the textbook An Introduction to Infectious Disease Modelling, published by Oxford University Press..
Research
Infectious disease modelling. Analysing seroprevalence data. Rubella. Previous work includes modelling influenza and tuberculosis.
Selected Publications
Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055.
2025
MMWR. Morbidity and mortality weekly report
Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
2024
International journal of infectious diseases
Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019.
2023
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program.
2023
International journal of infectious diseases
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
2022
The Lancet Global health